Rochester, NY, December 22, 2010 – ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, has announced several key appointments at its US site across administration, lab, operations, sales and data management.
Key appointments include Angela Panzarella, who has been announced as the new President of ACM Global Central Lab, Mary Williamson, PhD as Director of Laboratory Operations and Andrew Bascom as Director of Data Management & Clinical Systems. Panzarella has two decades of experience in executive leadership and strategic business development in regional, national, and global markets. Mary Williamson, PhD has a wealth of academic and scientific expertise to bring to her role in all areas and aspects of the Clinical Laboratory as a Registered Clinical Chemist (NRCC) and a Certified Medical Technologist (ASCP). Andrew has extensive experience in the area of laboratory informatics and most recently worked at Pfizer.
Furthermore, promotions within the organization include Tracy Hendershott as Vice President, Clinical Trials Global Operations and Brian Clark as Senior Business Development Director, North America, which are essential to ACM Global’s continued growth and success.
“We are delighted to announce the appointments of such a high calibre of industry professionals”, said Jerry Boxall, Managing Director of ACM Global Central Lab, Europe. “These new additions along with the promotions in the organization demonstrate ACM Global’s commitment to continue investing in its Central Lab business from both the scientific and new business perspectives, and further strengthen our position in the industry.
About ACM Global Central Lab
ACM Global Central Lab offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM’s services extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting.
For more information, visit www.acmgloballab.com
